Geert Cauwenbergh
2018
In 2018, Geert Cauwenbergh earned a total compensation of $610.4K as Former Chief Executive Officer at RXi Pharmaceuticals, a 44% increase compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $115,775 |
|---|---|
| Option Awards | $36,099 |
| Salary | $420,366 |
| Stock Awards | $37,590 |
| Other | $606 |
| Total | $610,436 |
Cauwenbergh received $420.4K in salary, accounting for 69% of the total pay in 2018.
Cauwenbergh also received $115.8K in non-equity incentive plan, $36.1K in option awards, $37.6K in stock awards and $606 in other compensation.
Rankings
In 2018, Geert Cauwenbergh's compensation ranked 11,218th out of 14,244 executives tracked by ExecPay. In other words, Cauwenbergh earned more than 21.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 11,218 out of 14,244 | 21st |
Division Manufacturing | 4,541 out of 5,765 | 21st |
Major group Chemicals And Allied Products | 1,720 out of 2,128 | 19th |
Industry group Drugs | 1,460 out of 1,817 | 20th |
Industry Pharmaceutical Preparations | 1,120 out of 1,391 | 20th |
Source: SEC filing on August 30, 2019.
Cauwenbergh's colleagues
We found one more compensation record of an executive who worked with Geert Cauwenbergh at RXi Pharmaceuticals in 2018.
2018
Gerrit Dispersyn
RXi Pharmaceuticals